Compass International Services Corporation Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (27)

Latest Posts

About This Stock More About This Stock
S Psychedelic Compounds-Based Stocks Index Imploding
Article By: Lorimer Wilson
Saturday, May 14, 2022 8:00 AM EDT
Our index of Psychedelic Compounds-Based Drug Stocks tracking clinical-stage startups still in R&D is down 60% YTD; it's -78% from its 2021 high.
In this article: ATAI, MNMD, CMPS, ZYNE, GHRS, ALID, CYBN
Read
S Psychedelic Stocks Continue To Decline In May
Article By: Lorimer Wilson
Sunday, May 8, 2022 12:01 AM EDT
The 10 companies in our Psychedelic Compounds-Based Drug Stocks Index are clinical-stage startups still in the product research and development of novel compounds with no products and no revenue.
In this article: ATAI, MNMD, CMPS, ZYNE, GHRS, CYBN, FTRP
Read
S Psychedelic Compounds-Based Drug Stocks Index Bounces Back
Article By: Lorimer Wilson
Sunday, March 20, 2022 2:40 AM EDT
Updating the stock performances of the 13 constituents in our Pure-Play Marijuana and Psychedelic Compounds-Based Drug Stocks Index: up last week but still down 32% YTD.
In this article: MNMD, CMPS, SEEL, CYBN, FTRP
Read
S Psychedelic & Marijuana Drug Stocks Continue To Decline
Article By: Lorimer Wilson
Sunday, February 27, 2022 11:54 AM EDT
Thirteen clinical-stage companies with the largest market capitalizations are tracked in our Pure-Play Marijuana (4) and Psychedelic Compounds-Based (9) Drug Stocks Indexes.
In this article: ATAI, MNMD, CMPS, ZYNE, CRBP, GHRS, FTRP
Read
S The Psychedelic & Marijuana Drug Stocks Index Dropped -30% In January
Article By: Lorimer Wilson
Sunday, January 30, 2022 11:50 AM EDT
This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses.
In this article: ATAI, MNMD, CMPS, ZYNE, CRBP, SEEL, GHRS, ALID, CYBN, FTRP, AWKNF, NUMIF
Read

Latest Tweets for $CMPS

No tweets yet!

PARTNER HEADLINES